bendamustine
Commercial- Indications
- Non-Hodgkin lymphoma, Multiple myeloma, Myelodysplastic syndrome
Company intelligence / Profile preview
SymBio Pharmaceuticals
Minato-ku, Tokyo, Japansymbiopharma.com ↗
- Ownership
- Public · 4582
- Employees
- ~108
- Development stage
- Commercial
01
Overview
SymBio Pharmaceuticals is a Japanese specialty pharmaceutical company focused on developing and commercializing innovative therapies for unmet medical needs in oncology and viral infections. Its lead programs include brincidofovir for viral infections and TREAKISYM (bendamustine) for hematologic malignancies. The company has achieved commercialization of some products in Japan and continues to expand indications through ongoing clinical trials.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- Small moleculeNucleoside analog
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Eagle PharmaceuticalsNational Institute of Neurological Disorders and Stroke (NINDS), US NIH
Beyond the preview
Go deeper on SymBio Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SymBio Pharmaceuticals.